Anandamide reduces the migration of lymphocytes to the intestine by CB2 activation and reduces TNF-a in the target organs, protecting mice from graft-versus-host disease
Berg, BB; Linhares, AFS; Martins, DM; Rachid, MA; Cau, SBD; de Souza, GG; de Carvalho, JCS; Sorgi, CA; Romero, TRL; Pinho, V; Teixeira, MM; Castor, MGME
Castor, MGME (通讯作者),Univ Fed Minas Gerais, Sch Med, Belo Horizonte, Brazil.;Castor, MGME (通讯作者),Univ Fed Minas Gerais, Inst Ciencias Biol, Lab Farmacol Cardiovasc & Inflamacao LAFACI A3 171, Belo Horizonte, MG, Brazil.
EUROPEAN JOURNAL OF PHARMACOLOGY, 2023; 956 ():